Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Am J Ophthalmol ; 187: 158-166, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-28887115

RESUMEN

PURPOSE: Provide baseline and preliminary follow-up results in a 5-year longitudinal study of Blau syndrome. DESIGN: Multicenter, prospective interventional case series. METHODS: Baseline data from 50 patients from 25 centers worldwide, and follow-up data for patients followed 1, 2, or 3 years at the end of study enrollment. Ophthalmic data were collected at baseline and yearly visits by means of a standardized collection form. RESULTS: Median age at onset of eye disease was 60 months and duration of eye disease at baseline 145 months. At baseline 38 patients (78%) had uveitis, which was bilateral in 37 (97%). Eight patients (21%) had moderate to severe visual impairment. Panuveitis was found in 38 eyes (51%), with characteristic multifocal choroidal infiltrates in 29 eyes (39%). Optic disc pallor in 9 eyes (12%) and peripapillary nodules in 9 eyes (12%) were the commonest signs of optic nerve involvement. Active anterior chamber inflammation was noted in 30 eyes (40%) at baseline and in 16 (34%), 17 (57%), and 11 (61%) eyes at 1, 2, and 3 years, respectively. Panuveitis was associated with longer disease duration. At baseline, 56 eyes (75%) were on topical corticosteroids. Twenty-six patients (68%) received a combination of systemic corticosteroids and immunomodulatory therapy. CONCLUSIONS: Blau uveitis is characterized by progressive panuveitis with multifocal choroiditis, resulting in severe ocular morbidity despite continuous systemic and local immunomodulatory therapy. The frequency and severity of Blau uveitis highlight the need for close ophthalmologic surveillance as well as a search for more effective therapies.


Asunto(s)
Artritis/diagnóstico , Sinovitis/diagnóstico , Uveítis/diagnóstico , Adolescente , Adulto , Antihipertensivos/uso terapéutico , Artritis/tratamiento farmacológico , Artritis/fisiopatología , Niño , Preescolar , Coroiditis/diagnóstico , Coroiditis/tratamiento farmacológico , Coroiditis/fisiopatología , Estudios Transversales , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Salud Global , Glucocorticoides/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Lactante , Masculino , Persona de Mediana Edad , Coroiditis Multifocal , Estudios Prospectivos , Sarcoidosis , Sinovitis/tratamiento farmacológico , Sinovitis/fisiopatología , Uveítis/tratamiento farmacológico , Uveítis/fisiopatología , Agudeza Visual/fisiología
2.
Rheumatology (Oxford) ; 54(6): 1008-16, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25416713

RESUMEN

OBJECTIVE: To report baseline articular, functional and ocular findings of the first international prospective cohort study of Blau syndrome (BS). METHODS: Three-year, multicentre, observational study on articular, functional (HAQ, Childhood HAQ and VAS global and pain), ophthalmological, therapeutic and radiological data in BS patients. RESULTS: Baseline data on the first 31 recruited patients (12 females and 19 males) from 18 centres in 11 countries are presented. Of the 31 patients, 11 carried the p.R334W NOD2 mutation, 9 the p.R334Q and 11 various other NOD2 missense mutations; 20 patients were sporadic and 11 from five BS pedigrees. Median disease duration was 12.8 years (1.1-57). Arthritis, documented in all but one patient, was oligoarticular in 7, polyarticular in 23. The median active joint count was 21. Functional capacity was normal in 41%, mildly impaired in 31% and moderate-severe in 28% of patients. The most frequently involved joints at presentation were wrists, ankles, knees and PIPs. On radiographs, a symmetrical non-erosive arthropathy was shown. Previously unknown dysplastic bony changes were found in two-thirds of patients. Ocular disease was documented in 25 of 31 patients, with vitreous inflammation in 64% and moderate-severe visual loss in 33%. Expanded manifestations (visceral, vascular) beyond the classic clinical triad were seen in 52%. CONCLUSION: BS is associated with severe ocular and articular morbidity. Visceral involvement is common and may be life-threatening. Bone dysplastic changes may show diagnostic value and suggest a previously unknown role of NOD2 in bone morphogenesis. BS is resistant to current drugs, suggesting the need for novel targeted therapies.


Asunto(s)
Artritis , Enfermedades de los Nervios Craneales , Oftalmopatías , Proteína Adaptadora de Señalización NOD2/genética , Enfermedades de la Piel , Sinovitis , Uveítis , Adolescente , Adulto , Artritis/diagnóstico por imagen , Artritis/tratamiento farmacológico , Artritis/genética , Artritis/fisiopatología , Niño , Preescolar , Enfermedades de los Nervios Craneales/diagnóstico por imagen , Enfermedades de los Nervios Craneales/tratamiento farmacológico , Enfermedades de los Nervios Craneales/genética , Enfermedades de los Nervios Craneales/fisiopatología , Estudios Transversales , Oftalmopatías/tratamiento farmacológico , Oftalmopatías/genética , Oftalmopatías/fisiopatología , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Mutación Missense , Estudios Prospectivos , Radiografía , Sarcoidosis , Enfermedades de la Piel/tratamiento farmacológico , Enfermedades de la Piel/genética , Enfermedades de la Piel/fisiopatología , Sinovitis/diagnóstico por imagen , Sinovitis/tratamiento farmacológico , Sinovitis/genética , Sinovitis/fisiopatología , Resultado del Tratamiento , Uveítis/diagnóstico por imagen , Uveítis/tratamiento farmacológico , Uveítis/genética , Uveítis/fisiopatología , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...